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Abstract. The mechanism of ‘down regulation’ of luteinizing hormone receptors was 
investigated in pseudopregnant rats using a modified radioimmunoassay capable of 
measuring endogenous tissue-bound hormone. Treatment of pseudopregnant animals with 
a desensitizing dose (desensitization treatment) of human chorionic gonadotropin resulted 
in a decrease in receptor concentration. This decrease was prevented if the animals were 
treated prior to the desensitization treatment with indomethacin, an inhibitor of 
prostaglandin biosynthesis, suggesting a role for prostaglandins in down regulation. The 
desensitization treatment resulted in a time-dependent decrease in subsequent responsive- 
ness of the tissue to luteinizing hormone. Basal progesterone production rate was also 
decreased following desensitization. Total tissue cholesterol was found to be decreased 
following desensitization treatment, without any change in the ratio of free to esterified 
cholesterol. Mitochondrial cholesterol was significantly reduced and pregnenolone 
production by the mitochondria of desensitized corpora lutea was also markedly reduced. 
However, when cholesterol was added to the mitochondria of desensitized corpora lutea, 
pregnenolone production was increased, reaching values almost equal to that shown by the 
control mitochondria. These results show that decrease in the responsiveness following 
desensitization treatment is due to, besides receptor loss, decrease in tissue cholesterol, in 
particular mitochondrial cholesterol. The cholesterol side chain cleavage activity, although 
low, appears to be functionally intact; the low activity could be attributed to low levels of 
mitochondrial cholesterol. 
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Introduction 
 
It is a well-recognized property of several hormones and drugs that the primary 
stimulus modulates the responsiveness of the target tissue to subsequent exposure of 
the same tissue to the same hormone. This phenomenon is known as ‘desensitization’ 
or ‘down regulation’ and has been demonstrated for several hormones and growth 
factors. Administration of luteinizing hormone (LH) or human chorionic 
gonadotropin (hCG) has been shown to cause decrease in LH receptors both in 
ovaries and testes (Dufau and Catt, 1979). Such a decrease in receptors is also 
followed by decrease in responsiveness of the tissue to the same stimulus (Dufau and 
Catt, 1979). It was further demonstrated that steroidogenesis in desensitized tissue 
could not be stimulated by dibutyryl cAMP or cholera toxin, suggesting a defective 
steroidogenic pathway (Conti et al., 1977). However, the mechanism by which the 
hormones cause decrease in the receptors and alter the responsiveness of the tissue is 
poorly understood. In the present study an attempt has been made to unravel the 
mechanism by which LH receptor loss and decrease in responsiveness occur using 
corpora lutea from pseudopregnant rats as the model system. 
 
 
Abbreviations used: LH, Luteinizing hormone; hCG, human chorionic gonadotropin; oLH, ovine LH; 
PMSG, pregnant mare serum gonadotropin; RIA, radioimmunoassay; SSC, side chain cleavage.
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Materials and methods 
 
 
Hormones and chemicals 
 
hCG used in this study was a kind gift of Dr C. R. Canfield, USA. Ovine LH (oLH) 
was a gift of Dr M. R. Sairam, Canada. Pregnant mare serum gonadotropin (PMSG)
was purchased from Sigma Chemical Co., St. Louis, Missouri, USA. [3H] Proges- 
terone, [3H]pregnenolone and Na125 I were purchased from the Radiochemical
Centre, Amersham, UK. All reagents used in this study were of analytical grade.
 
 
Animals 
 
Immature female rats 25–26 days of age were rendered pseudopregnant by injecting 
subcutaneously 15 IU of PMSG followed 56 h later by 50 IU of hCG. Four to five 
days after hCG treatment the animals were treated with either saline or a 
desensitizing dose of hCG (referred to hereafter as ‘desensitization treatment’) and 
killed after various times depending on the experimental design. Ovaries were
removed, and corpora lutea were dissected free of adhering fat using a fine needle 
and processed according to different experimental designs. 
 
 
Radioimmunoassay of tissue-bound hCG 
 
Luteal tissue-bound hCG was determined essentially according to the procedure 
previously used for tissue-bound LH (Muralidhar and Moudgal, 1976a, b) and tissue- 
bound follicle stimulating hormone (Sheela Rani and Moudgal, 1978). Corpora lutea 
were homogenized in 0·05 Μ Tris-HCl, 0·05 Μ EDTA, pH 7·4, and different aliquots 
were used for assaying hCG in the tissue by radioimmunoassay (RIA) carried out at 
37°C as described by Muralidhar and Moudgal (1976a, b). 
 
 
Determination of responsiveness of corpora lutea 
 
Responsiveness of the corpora lutea from control and hCG-treated animals to LH 
was determined by incubating the corpora lutea in Krebs–Ringer bicarbonate 
medium, pH 7·4, containing 0·05 Μ Hepes and 0·1 % bovine serum albumin (BSA) in 
the absence or presence of LH (0·1, 1 and 10 µg/ml oLH) for 2 h at 37°C. Proges- 
terone secreted into the medium was estimated by a specific RIA. 
 
 
Determination of luteal tissue cholesterol 
 
Corpora lutea were obtained from animals killed 12 or 24 h after desensitization 
treatment. The corpora lutea from individual animals were suspended in saline and 
stored frozen until further use. To determine luteal tissue cholesterol and esterified 
cholesterol, corpora lutea were homogenized in 0·15 Μ NaCl and total lipids were 
extracted using a chloroform: methanol mixture (final composition, chloroform: 
methanol: saline 1:1:0·9). Cholesterol and esterified cholesterol were separated by 
thin-layer chromatography using hexane: ether: acetic acid (30:10:0·5) as the 
solvent system and estimated by the method of Glick et al. (1964).
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Determination of cholesterol side chain cleavage activity 
 
Cholesterol side chain cleavage (SSC) activity of the mitochondria-rich preparation 
was assayed by estimating pregnenolone produced by the mitochondria. Corpora 
lutea were homogenized in 0·05 Μ Tris-HCl, pH 7·4, containing 0·5 mM EDTA and 
0·25 Μ sucrose. The homogenate was spun at 600 g for 10 min. The supernatant was 
retrieved and centrifuged at 8500 g for 15 min. The pellet was resuspended in the 
same buffer after washing and used for determining SSC activity. Aliquots of 
mitochondria (approximately 300 µg protein) were incubated in a total volume of 
1 ml of a solution containing 5 mM Ca2+, 5 mM Mg2+, 40 mM nicotinamide, and 
10 mM sodium succinate. Cholesterol (100 μΜ), whenever present, was added in 
50 μl absolute ethanol; all other aliquots received the same volume of ethanol. The 
reaction was initiated by adding the mitochondrial preparation and was continued 
for 30 min at 37°C. The reaction was terminated by placing the tubes in a boiling 
water bath for 1 min. Steroids formed were extracted with ether, and separated by 
thin-layer chromatography using chloroform: ethyl acetate (4:1) as the solvent 
system. Using this system, it was possible to separate pregnenolone from proges- 
terone. Pregnenolone was then estimated by RIA using 7-[3H]–pregnenolone as the 
tracer and a progesterone antiserum with 100% cross-reactivity with pregnenolone. 
 
Results 
 
Demonstration of down regulation of LH receptors 
 
Pseudopregnant rats were treated subcutaneously with saline or a desensitizing dose 
of hCG (4 µg). The animals were again treated after 48 h with hCG (2 or 4 µg) and 
killed 3 h later. Tissue-bound hCG was determined by RIA. It was earlier found that 
maximum uptake of hCG by the ovaries occurs 3 h after a subcutaneous injection of 
hCG and the uptake was maximal when 4 μg of hCG were administered, suggesting 
saturation of LH receptors in vivo. As shown in table 1, animals that had received 
desensitization treatment showed a significant decrease in uptake of hCG, 
demonstrating down regulation of LH receptors following desensitization treatment. 
 
Involvement of prostaglandins in down regulation of LH receptors 
 
The involvement of prostaglandins in the process of down regulation of LH 
 
 
Table 1. Down regulation of LH receptors. 
 
*Values are mean ± SD, n = 4. 
Group Ε significantly different from Group B, P < 0·001. 
Group F significantly different from Group C, Ρ < 0·001.
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receptors was investigated by studying the effect of a prostaglandin synthesis 
inhibitor on hCG-induced receptor loss. The animals were administered 1 and 4 μg 
of hCG as a desensitization treatment and uptake of hCG 3 h following the adminis- 
tration of 5 µg of hCG 48 h after desensitization was determined. One group of 
animals was treated with 500 µg indomethacin 1 h prior to desensitization treatment 
and hCG uptake by luteal tissue was determined as described above. As shown in
table 2, the desensitizaton treatment resulted in a dose-dependent decrease in hCG
 
 
Table 2. Effect of indomethacin on hCG-induced receptor loss. 
 
*Values are mean ± SD, n = 4. 
Significance of difference: C vs A, P < 0·001; G vs Α, Ρ < 0·001; Ε vs C. 
P < 0·005; H vs G, Ρ < 0·005. 
ND, Not determined. 
 
 
uptake by the corpora lutea, suggesting loss of LH receptors. Indomethacin 
treatment reduced receptor loss. This effect was only marginal when the desensitizing 
dose was 4 µg but completely prevented receptor loss when the desensitizing dose
was 1 µg. 
 
 
Effect of desensitization treatment on responsiveness of the corpora lutea 
 
Corpora lutea obtained from rats after various times following desensitization 
treatment were incubated with different concentrations of oLH or without oLH for 
2 h at 37°C. Progesterone secreted into the medium was estimated by RIA. As shown 
in figure 1, the control corpora lutea (0 h) responded to LH in vitro by producing 
increased progesterone. However, the corpora lutea obtained 4, 12, 24 and 48 h after 
the desensitizing dose did not show any responsiveness to LH added in vitro. The 
corpora lutea obtained 4 h after desensitizing treatment showed increased basal 
production in vitro but did not show any further responsiveness. Corpora lutea 
obtained 12, 24 and even 48 h after the desensitization treatment showed decreased 
basal production of progesterone. 
 
 
Effect of desensitization treatment on sterol levels of luteal tissue 
 
Endogenous cholesterol and esterified cholesterol levels were determined in luteal
tissue 12 and 24 h following desensitization treatment. Untreated animals served as
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Figure 1. In vitro responsiveness of the corpora lutea following a desensitization
treatment. Corpora lutea were obtained from animals 4, 12, 24 and 48 h after treatment;
0 h indicates untreated animals (control). Each point is the mean ± SD of triplicates.
 
 
controls. As shown in table 3 there was a significant decrease in cholesterol levels
(P < 0·05), although by 24 h the cholesterol levels appear to be higher than at 12 h 
 
 
Table 3. Endogenous free and esterified cholesterol in control and desensitized corpora
lutea. 
 
*Values are mean ± SD, n = 4. 
Significance of difference: Cholesterol 12 h vs 0 h, P < 0·05; cholesterol 24 h vs 0 h, not 
significant; cholesterol ester, 12 h vs 0 h, Ρ < 0·05; cholesterol ester 24 h vs 0 h, not
significant; total cholesterol 12 h vs 0 h, Ρ  0·05. 
 
 
and not significantly different from 0 h levels. A similar pattern was observed for 
esterified cholesterol, and for free and esterified cholesterol taken together (total 
cholesterol). However, total cholesterol present in the mitochondria obtained from 
pooled corpora lutea was markedly reduced even 24 h after the desensitization
treatment (table 4). 
 
Effect of desensitization treatment on cholesterol side chain cleavage activity 
 
Mitochondria prepared from corpora lutea obtained from control and hCG-
desensitized animals were used for determining cholesterol side chain cleavage
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Table 4. Cholesterol levels in mitochon-
dria-rich preparation obtained from
control and desensitized corpora lutea. 
 
Animals were killed 24 h after treatment. 
 
 
activity. As shown in table 5, pregnenolone production by mitochondria from hCG-
treated rats was significantly lower than that by control mitochondria. While
addition of exogenous cholesterol to mitochondria from control corpora lutea did
 
 
Table 5. Cholesterol side chain cleavage activity in control 
and desensitized luteal mitochondria. 
 
Animals were killed 24 h after desensitization treatment or
saline injection (control). 
*Values are mean ± SD, n = 4. 
Significance of difference: Β vs Α, Ρ < 0·001; D vs Β, Ρ < 0·025; 
C vs D, not significant. 
 
 
 
not enhance pregnenolone formation, the mitochondria from desensitized luteal
tissue showed stimulated production of pregnenolone and this was equal to that
produced by the control mitochondria.
 
 
Discussion 
 
In the studies presented above an attempt has been made to understand the 
mechanism of down regulation of LH receptors and the subsequent reduction in 
responsiveness of the corpora lutea. The down regulation of receptors was 
demonstrated using an RIA system extensively validated earlier (Muralidhar and 
Moudgal, 1976a, b; Sheela Rani and Moudgal, 1978; Dighe, 1982) for measurement of 
physiologically active LH bound to receptors. With this assay system it has been 
demonstrated here that decrease in hormone uptake following desensitization 
treatment was indeed due to a true loss of the receptors and not due to decrease in 
binding of the hormone to the receptors caused by higher occupancy of the receptors 
after the desensitization treatment. 
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Prostaglandins have been implicated in bringing about luteolysis in several species 
Labhsetwar, 1975; Zor and Lamprecht, 1977; Behrman, 1979). Prostaglandins have 
also been shown to cause reduction in LH receptor concentration (Hichens et al., 
1974; Grinwich et al., 1976a, b; Behrman and Hichens, 1976; Behrman et al., 1978). In 
the present study it has been shown that inhibition of prostaglandin biosynthesis by 
indomethacin treatment prevented hCG-induced receptor loss. The protection 
provided by indomethacin was dependent on the dose of indomethacin, 500 μg being 
the most effective dose (data not shown). At this dose inhibition of receptor loss was 
partial if the desensitizing dose of hCG was 4 μg but complete inhibition of receptor 
loss was observed when the desensitization dose of hCG was reduced to 1 µg. These 
results provide confirmatory evidence for the involvement of prostaglandins in
regulating luteal cell LH receptor concentration. One of the events that occur 
following binding of the hormone to the receptor is perhaps stimulation of prosta- 
glandin biosynthesis which in turn initiates down regulation of receptor. Haour et al. 
(1979a, b) have noted that in the Leydig cell prostaglandin levels increase 6 h following 
hCG administration. In the present study it was also found that administration of 
indomethacin 90 min or 6 h after desensitization treatment did not prevent the 
receptor loss (data not shown). Thus receptor loss, once initiated, could not be 
prevented by indomethacin administration. 
A decrease in the receptor concentration was also accompanied by decrease in 
responsiveness of the corpora lutea. Progesterone production decreased in a time- 
dependent fashion and was reflected both in basal rate of progesterone production as 
well as in response to LH in vitro. This suggested that in addition to receptor loss 
significant alterations in the progesterone biosynthetic pathway should be occurring. 
There is a large body of evidence to show that loss of LH receptors is also 
accompanied by several lesions in the steroid biosynthetic pathway. Luteal adenylyl 
cyclase activity was found to be decreased following administration of a desensitizing 
dose of hCG to pseudopregnant rabbits (Hunzicker-Dunn and Birnbaumer, 1976). 
Further, it was shown that desensitized Leydig cells responded to cholera toxin with 
increased cAMP production, but failed to respond in terms of testosterone 
production (Tsuruhara et al., 1977). It has also been observed that desensitized luteal 
cells do not respond to cholera toxin and dibutyryl cAMP in terms of progesterone 
production (Conti et al., 1977). In the case of Leydig cells the lesion in testosterone 
biosynthesis was identified as a decrease in the activities of the enzymes 17–20 lyase 
(Cigorraga et al., 1978) and 17α hydroxylase (Chaslow et al., 1979). However, such 
defects have not been identified in luteal cells. The levels of cholesterol and esterified 
cholesterol were found to be decreased in corpora lutea obtained from hCG-treated
animals. However it must be noted that there was no decrease in the ratio of free to 
esterified cholesterol. Down regulation, as described here, results in decrease in 
progesterone biosynthesis and this is similar to that occurring in corpora lutea
undergoing functional luteolysis. Blockade or reduction in endogenous LH 
availability brought about by LH antibody treatment resulted in significant 
accumulation of esterified cholesterol in the luteal tissue (Moudgal et al., 1972; 
Behrman et al., 1972; Mukku and Moudgal, 1980) and this was unlike that observed 
in desensitized corpora lutea. Corpora lutea undergoing luteolysis remained 
responsive to added LH in vitro in terms of progesterone production, though this 
declined with time (Mukku and Moudgal, 1980); however, the desensitized corpora 
lutea did not respond to LH at all. These results suggest that there is a fundamental
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difference between luteolysis brought about by LH removal and desensitization 
brought about by LH receptor down regulation. 
The desensitized corpora lutea also showed marked decrease in mitochondrial 
cholesterol. Only part of the mitochondrial cholesterol is available to the side chain 
cleavage activity (see Dorrington, 1977). Hence the effect of a decrease in the choles- 
terol level of mitochondria on side chain cleavage activity is probably enhanced 
further. There was a significant decrease in pregnenolone production by 
mitochondria from desensitized corpora lutea. This defect in pregnenolone 
biosynthesis could be ameliorated by addition of cholesterol to the mitochondrial 
preparation: pregnenolone production by mitochondria from desensitized corpora 
lutea in the presence of exogenous cholesterol was nearly equal to that by control 
mitochondria. These results suggest that the cholesterol side chain cleavage activity 
is probably functionally intact, and the decrease in progesterone biosynthesis could 
be due to the decrease in the cholesterol pool in mitochondria which acts as the 
substrate for cholesterol side chain cleavage enzymes. Replenishment of the 
mitochondrial cholesterol pool may take a much longer time than that of tissue 
cholesterol. Levels of tissue cholesterol had returned to nearly control levels 24 h 
following desensitization treatment, but cholesterol in the mitochondria remained 
markedly reduced. There was no change in 3ß-hydroxy-steroid dehydrogenase in 
desensitized corpora lutea but a significant increase in cAMP phosphodiesterase 
activity was noted (data not shown). This defect can cause further decrease in progres- 
terone biosynthesis. 
Thus down regulation of luteal tissue following administration of hCG occurs at 
at least two different levels—(i) loss of receptors which is perhaps mediated by 
prostaglandins and (ii) decrease in the cholesterol pool resulting in decrease in 
progesterone production. 
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